Immune dysfunction in the elderly: Effect of thymic hormone administration on several in vivo and in vitro immune function parameters

Umberto Fagiolo, A. Amadori, F. Borghesan, R. Zamarchi, M. L. Veronese, G. De Silvestro, E. Passarella, G. Crepaldi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The effects of short- term thymic hormone administration on age- associated immune function were evaluated. Two groups of individuals > 65 years of age were treated for 30 days with thymic extracts (TP1) or placebo; before and after this treatment a panel of in vitro and in vivo parameters was determined according to a very rigorous experimental protocol. In most individuals, TP1 treatment was associated with an improvement in cutaneous delayed- type response to PPD. Moreover, an increase in a circulating T cell subpopulation bearing the CD45R surface antigen (“virgin” T cells), and in NK cell cytotoxic activity was also observed in some subjects. Finally, lymphocyte responsiveness to PHA tended to increase, while no effect on lymphocyte ability to produce IL- 2 following mitogen stimulation was observed. These findings suggest that TP1 treatment may influence age- related alterations in immune function parameters in some subjects. (Again 2: 347–355, 1990)

Original languageEnglish
Pages (from-to)347-355
Number of pages9
JournalAging clinical and experimental research
Volume2
Issue number4
DOIs
Publication statusPublished - 1990

Fingerprint

Thymus Hormones
Lymphocytes
CD45 Antigens
T-Lymphocytes
Tuberculin
Surface Antigens
Mitogens
Natural Killer Cells
Interleukin-2
Therapeutics
Placebos
Skin
In Vitro Techniques

Keywords

  • age-associated immune defect
  • Aging
  • immunotherapy
  • thymic hormones
  • TP1

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Cite this

Immune dysfunction in the elderly : Effect of thymic hormone administration on several in vivo and in vitro immune function parameters. / Fagiolo, Umberto; Amadori, A.; Borghesan, F.; Zamarchi, R.; Veronese, M. L.; De Silvestro, G.; Passarella, E.; Crepaldi, G.

In: Aging clinical and experimental research, Vol. 2, No. 4, 1990, p. 347-355.

Research output: Contribution to journalArticle

Fagiolo, Umberto ; Amadori, A. ; Borghesan, F. ; Zamarchi, R. ; Veronese, M. L. ; De Silvestro, G. ; Passarella, E. ; Crepaldi, G. / Immune dysfunction in the elderly : Effect of thymic hormone administration on several in vivo and in vitro immune function parameters. In: Aging clinical and experimental research. 1990 ; Vol. 2, No. 4. pp. 347-355.
@article{e0ccdcaeb8e14066ab62e2ee1ffdcc33,
title = "Immune dysfunction in the elderly: Effect of thymic hormone administration on several in vivo and in vitro immune function parameters",
abstract = "The effects of short- term thymic hormone administration on age- associated immune function were evaluated. Two groups of individuals > 65 years of age were treated for 30 days with thymic extracts (TP1) or placebo; before and after this treatment a panel of in vitro and in vivo parameters was determined according to a very rigorous experimental protocol. In most individuals, TP1 treatment was associated with an improvement in cutaneous delayed- type response to PPD. Moreover, an increase in a circulating T cell subpopulation bearing the CD45R surface antigen (“virgin” T cells), and in NK cell cytotoxic activity was also observed in some subjects. Finally, lymphocyte responsiveness to PHA tended to increase, while no effect on lymphocyte ability to produce IL- 2 following mitogen stimulation was observed. These findings suggest that TP1 treatment may influence age- related alterations in immune function parameters in some subjects. (Again 2: 347–355, 1990)",
keywords = "age-associated immune defect, Aging, immunotherapy, thymic hormones, TP1",
author = "Umberto Fagiolo and A. Amadori and F. Borghesan and R. Zamarchi and Veronese, {M. L.} and {De Silvestro}, G. and E. Passarella and G. Crepaldi",
year = "1990",
doi = "10.1007/BF03323947",
language = "English",
volume = "2",
pages = "347--355",
journal = "Aging clinical and experimental research",
issn = "1594-0667",
publisher = "Springer International Publishing AG",
number = "4",

}

TY - JOUR

T1 - Immune dysfunction in the elderly

T2 - Effect of thymic hormone administration on several in vivo and in vitro immune function parameters

AU - Fagiolo, Umberto

AU - Amadori, A.

AU - Borghesan, F.

AU - Zamarchi, R.

AU - Veronese, M. L.

AU - De Silvestro, G.

AU - Passarella, E.

AU - Crepaldi, G.

PY - 1990

Y1 - 1990

N2 - The effects of short- term thymic hormone administration on age- associated immune function were evaluated. Two groups of individuals > 65 years of age were treated for 30 days with thymic extracts (TP1) or placebo; before and after this treatment a panel of in vitro and in vivo parameters was determined according to a very rigorous experimental protocol. In most individuals, TP1 treatment was associated with an improvement in cutaneous delayed- type response to PPD. Moreover, an increase in a circulating T cell subpopulation bearing the CD45R surface antigen (“virgin” T cells), and in NK cell cytotoxic activity was also observed in some subjects. Finally, lymphocyte responsiveness to PHA tended to increase, while no effect on lymphocyte ability to produce IL- 2 following mitogen stimulation was observed. These findings suggest that TP1 treatment may influence age- related alterations in immune function parameters in some subjects. (Again 2: 347–355, 1990)

AB - The effects of short- term thymic hormone administration on age- associated immune function were evaluated. Two groups of individuals > 65 years of age were treated for 30 days with thymic extracts (TP1) or placebo; before and after this treatment a panel of in vitro and in vivo parameters was determined according to a very rigorous experimental protocol. In most individuals, TP1 treatment was associated with an improvement in cutaneous delayed- type response to PPD. Moreover, an increase in a circulating T cell subpopulation bearing the CD45R surface antigen (“virgin” T cells), and in NK cell cytotoxic activity was also observed in some subjects. Finally, lymphocyte responsiveness to PHA tended to increase, while no effect on lymphocyte ability to produce IL- 2 following mitogen stimulation was observed. These findings suggest that TP1 treatment may influence age- related alterations in immune function parameters in some subjects. (Again 2: 347–355, 1990)

KW - age-associated immune defect

KW - Aging

KW - immunotherapy

KW - thymic hormones

KW - TP1

UR - http://www.scopus.com/inward/record.url?scp=0025611039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025611039&partnerID=8YFLogxK

U2 - 10.1007/BF03323947

DO - 10.1007/BF03323947

M3 - Article

C2 - 2094375

AN - SCOPUS:0025611039

VL - 2

SP - 347

EP - 355

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

IS - 4

ER -